The clinical challenge of cardiorenal syndrome.
Shlipak
Michael G
MG
Massie
Barry M
BM
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D019090:Case Management; D015331:Cohort Studies; D003404:Creatinine / Q000097:blood; D018450:Disease Progression; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D005544:Forecasting; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006333:Heart Failure / Q000150:complications / Q000401:mortality / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology / Q000628:therapy*; D020097:Natriuretic Peptide, Brain / Q000494:pharmacology / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012079:Renal Circulation / Q000187:drug effects; D013577:Syndrome
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D020097:Natriuretic Peptide, Brain; D003404:Creatinine; D005996:Nitroglycerin